This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Piramal Enterprises Limited. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2021
Title: Innovations of Arun Balakrishnan in Pharmaceutical Development
Introduction
Arun Balakrishnan is a notable inventor based in Mumbai, India, recognized for his contributions to the field of pharmaceuticals. He has been instrumental in developing innovative treatments for various medical conditions, particularly in oncology.
Latest Patents
Arun Balakrishnan holds two patents, with his latest invention focusing on a synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of the head and neck. This invention involves a pharmaceutical combination that includes a CDK inhibitor and one or more antineoplastic agents such as sorafenib, lapatinib, erlotinib, cisplatin, 5-fluorouracil, docetaxel, or cetuximab. The combination exhibits synergy in treating squamous cell carcinoma, providing a promising approach to enhance therapeutic efficacy.
Career Highlights
Arun Balakrishnan is currently associated with Piramal Enterprises Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including Veena R Agarwal and Giridharan Periyasamy, to further enhance the impact of his research and inventions.
Conclusion
Arun Balakrishnan's innovative work in pharmaceutical combinations showcases his dedication to addressing critical health challenges. His contributions are paving the way for more effective treatments in oncology, reflecting the importance of innovation in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile